Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,484 across all filing types
Latest filing 2022-09-29 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 26 September 2022.
Director's Dealing Classification · 100% confidence The document explicitly states it is a "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions executed by an entity related to an individual associated with the company (Vesela Stoeva) involving the company's warrants. This directly corresponds to the definition of Director's Dealing (insider trades by directors and executives). Therefore, the appropriate filing code is DIRS.
2022-09-29 English
Shareholding notification from "Telso" AD
Major Shareholding Notification Classification · 99% confidence The document is a 'Current report' dated September 29, 2022, titled 'NOTIFICATION'. It explicitly states that the company received a 'shareholding notification' from 'Telso' AD, indicating that 'Telso' AD reached 5% in the capital of 'Sopharma' AD. This directly corresponds to the definition of a Major Shareholding Notification (crossing ownership thresholds). Therefore, the appropriate code is MRQ.
2022-09-29 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 27 September 2022.
Director's Dealing Classification · 100% confidence The document is explicitly titled 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It details transactions (Buy operations) executed by an entity ('Telso' AD) related to an individual associated with the company ('Vesela Stoeva') involving the company's shares. This directly matches the definition for Director's Dealing (insider trades by directors and executives). The corresponding code is DIRS.
2022-09-28 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 27 September 2022.
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It details transactions executed by Mr. Ognian Donev, the Chairman of the Board of Directors, regarding the Company's shares. This directly corresponds to the definition of Director's Dealing (insider trades by executives).
2022-09-28 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 26 September 2022.
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions executed by Mr. Ognian Donev, the Chairman of the Board of Directors, involving the purchase of warrants. This directly corresponds to the definition of Director's Dealing (insider trades by directors/executives). Therefore, the correct classification code is DIRS.
2022-09-27 English
Sales revenues for August 2022
Earnings Release Classification · 100% confidence The document is titled "Current report №70/ 2022 Dated September 7, 2022" and provides a brief notification regarding sales performance for August 2022 and the eight-month period year-to-date. This format, providing key financial highlights immediately upon reporting period closure, strongly aligns with an Earnings Release (ER), which covers initial announcements of periodical financial results (key highlights only). It is too brief and high-level to be a comprehensive Interim Report (IR) or Annual Report (10-K). Since it is a notification of financial performance, ER is the most appropriate specific code. 9M 2022
2022-09-07 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.